Salinosporamide B

• CAT Number: I035951
• CAS Number: 863126-95-8
• Molecular Formula: C15H21NO4
• Molecular Weight: 279.33
• Purity: 98%
• Synonyms: Salinosporamide B
• Solubility: Soluble in DMSO
• Appearance: Solid powder
• Storage: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
• IUPAC Name: (1R,4R,5S)-1-(((S)-cyclohex-2-en-1-yl)(hydroxy)methyl)-4-ethyl-5-methyl-6-oxa-2-azabicyclo[3.2.0]heptane-3,7-dione
• InChI: InChI=1S/C15H21NO4/c1-3-10-12(18)16-15(13(19)20-14(10,15)2)11(17)9-7-5-4-6-8-9/h5,7,9-11,17H,3-4,6,8H2,1-2H3,(H,16,18)/t9-,10+,11?,14+,15+/m1/s1
• InChIKey: SCJZQKFFYIGMCI-BOZRLRFCSA-N
• SMILES: O=C([C@H](CC)[C@]1(C)O2)N[C@@]1(C([C@@H]3C=CCCC3)O)C2=O

Salinosporamide B(CAT: I035951) is a natural product derived from marine actinomycetes, known for its potential as a proteasome inhibitor. It is structurally related to Salinosporamide A but exhibits distinct biological activity, making it a valuable compound for research into proteasome function, protein degradation pathways, and cancer therapy. Salinosporamide B is instrumental in exploring the mechanisms of proteasome-mediated cell cycle regulation and apoptosis, particularly in oncology studies. Its high purity and reliability make it an essential tool for advancing research in drug discovery and understanding proteasome-related cellular processes.